Richard Adcock insider trades

Open-market stock purchases and sales by Richard Adcock, CEO & President at ImmunityBio, Inc, from SEC Form 4 filings since Feb 5, 2021.

Recent trades

DateStockTradeValue
Feb 22, 2026IBRX ImmunityBio, IncSold (not open market)$675K
Feb 22, 2026IBRX ImmunityBio, IncBought (not open market)—
Feb 10, 2026IBRX ImmunityBio, IncSold (not open market)$971K
Feb 10, 2026IBRX ImmunityBio, IncBought (not open market)—
Dec 31, 2025IBRX ImmunityBio, IncSold (not open market)$34.7K
Dec 31, 2025IBRX ImmunityBio, IncBought (not open market)—

Companies traded

  • IBRX ImmunityBio, Inc: 2 buys, last Feb 22, 2026
  • NK NantKwest, Inc: other filings, last Feb 5, 2021

Get free alerts when Richard Adcock files a new trade →